Literature DB >> 3495578

Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.

P W Johnson, W S Trimble, N Hozumi, J C Roder.   

Abstract

C3H 10T1/2 mouse fibroblasts were transfected with a plasmid vector composed of EJ, the mutated c-Ha-ras, and a metallothionein promotor that induced amplified ras expression when activated by culture in the presence of zinc. Experiments were conducted to compare the effect of induction on killing by activated natural killer (NK) cells, cytotoxic T lymphocytes, activated macrophages, and antibody plus complement. The only effector that recognized increased ras expression and exhibited high-inducible cytolysis was an activated NK cell. The effectors from spleen were poly I.C. boostable, Lyt-1.1 negative, NK 1.2 positive, and asialo GM1 positive. Spleen cells from T cell-deficient nude mice, but not NK-deficient beige mice, exhibited high levels of killing activity, and experiments with NK cell clones demonstrated that these lines were also highly cytolytic and killed Ha-ras transfectants in parallel to YAC. Transfection of the same fibroblast line with c-myc did not alter the level of activated NK sensitivity. Cold target competition experiments revealed that Ha-ras-transfected and non-transfected 10T1/2 fibroblasts competed equally for lysis of either YAC or Ha-ras transfectants. Rat-1 fibroblasts did not compete, but gained this capacity when transformed with the v-Ki-ras oncogene but not v-fps. These data suggest that Ha-ras acts in target cells at a post-binding step, whereas Ki-ras may affect expression of target-effector binding structures. The findings that activated NK cell lysis may be specifically influenced by ras expression support a role for NK cells in host surveillance against early neoplastic changes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity.

Authors:  T A Walker; B A Wilson; A M Lewis; J L Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

2.  The in vivo clearance of Ha-ras transformants by natural killer cells.

Authors:  P W Johnson; J Stankova; D Dexter; J C Roder
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

3.  ras transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cells.

Authors:  A B Tuck; S M Wilson; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

4.  Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies.

Authors:  D W Hoskin; J Stankova; S K Anderson; J C Roder
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Experimental metastasis of oncogene-transformed NIH 3T3 cells in chick embryo.

Authors:  Y Endo; M Seiki; H Uchida; M Noguchi; Y Kida; H Sato; M Mai; T Sasaki
Journal:  Jpn J Cancer Res       Date:  1992-03

6.  Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).

Authors:  M Marubayashi; R Solana; R Ramirez; E Aranda; F Galan; J Peña
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

7.  Intercellular transfer of oncogenic H-Ras at the immunological synapse.

Authors:  Oded Rechavi; Itamar Goldstein; Helly Vernitsky; Barak Rotblat; Yoel Kloog
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.